Privia Health Group, Inc. (PRVA) shares surged 5.10% in pre-market trading on Thursday following the release of its impressive first-quarter 2025 financial results and an upbeat full-year outlook. The healthcare company reported better-than-expected earnings and raised its guidance, despite a revenue miss.
For Q1 2025, Privia Health posted non-GAAP earnings of $0.22 per share, surpassing the FactSet analyst consensus of $0.19 and marking a 22.22% increase from the same period last year. The company's adjusted EBITDA reached $26.9 million, significantly beating the estimated $23.4 million. However, revenue came in at $480.1 million, falling short of the $777.1 million forecast but still representing a 15.62% year-over-year growth.
Investors were particularly encouraged by Privia Health's decision to raise its full-year 2025 outlook to the mid- to high-end of its guidance ranges for all metrics, with attributed lives remaining unchanged. This optimistic forecast, coupled with the company's recent expansion into the Arizona market through a strategic acquisition, signals strong growth potential and operational execution. The positive sentiment surrounding these developments appears to be the primary driver behind the stock's pre-market rally.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.